Features of Coxsackie B virus (CBV) infection in children with prolonged physical and psychological morbidity.
Wilson, P M, Kusumakar, V, McCartney, R A et al. · Journal of psychosomatic research · 1989 · DOI
Quick Summary
This study looked at 39 children who were sick and tested them for Coxsackie B virus infection. Eighteen of the children had evidence of this virus. Most children, whether infected or not, complained of muscle weakness and tiredness. Children who had the virus were more likely to have family members with the same virus and to feel sad or anxious.
Why It Matters
This study is historically significant as it identified a potential viral trigger for a syndrome characterized by fatigue, muscle pain, and psychological symptoms in children—features central to understanding ME/CFS pathogenesis. The proposal to recognize fatigue and mood disturbance as core features, rather than emphasizing encephalomyelitis, influenced how subsequent researchers conceptualized post-viral illnesses. The familial clustering of CBV infection suggests possible shared genetic or environmental susceptibility factors relevant to ME/CFS.
Observed Findings
Eighteen of 39 children (46%) had serological evidence of Coxsackie B virus infection.
Muscle weakness and easy fatigability were the most common complaints in both seropositive and seronegative children.
Children with CBV seropositivity were significantly more likely to belong to higher socioeconomic classes (I–II).
Family members of seropositive children were more likely to have serological evidence of CBV infection.
Seropositive children showed more dysphoric features and sore throats than seronegative children.
Inferred Conclusions
Coxsackie B virus infection is associated with a clinical syndrome characterized by fatigue, myalgia, and dysphoria in children.
The term 'myalgic encephalomyelitis' may be inappropriate for describing this post-viral condition and should be reconsidered.
The authors propose 'fatigue-dysphoria syndrome' as a more accurate descriptive term that better captures the observed clinical presentation.
Genetic or familial factors may predispose individuals to both CBV infection and the development of post-viral symptoms.
Remaining Questions
Does Coxsackie B virus actually cause the observed syndrome, or are infected and uninfected children equally susceptible to developing these symptoms?
What This Study Does Not Prove
This study does not prove that Coxsackie B virus causes ME/CFS or post-viral syndrome, only that some infected children develop these symptoms. The lack of controls and the retrospective design mean we cannot determine whether CBV infection is necessary, sufficient, or merely coincidental to symptom development. The study also does not establish whether the proposed 'fatigue-dysphoria syndrome' is distinct from other post-viral conditions or represents a unique disease entity.
Tags
Symptom:PainFatigue
Biomarker:Blood Biomarker
Phenotype:Infection-TriggeredPediatric
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
What is the natural history and long-term prognosis of children with this 'fatigue-dysphoria syndrome'—do symptoms resolve, persist, or worsen over time?
What mechanisms explain the association between CBV infection and dysphoric symptoms; is this direct viral effect on the nervous system or secondary to chronic illness?
Why does socioeconomic class appear to be associated with CBV seropositivity and symptom development?